Holen Sie sich die Stockscreener-App
0.445
2.53%
0.011
Handel nachbörslich:
.45
0.005
+1.12%
Schlusskurs vom Vortag:
$0.434
Offen:
$0.4402
24-Stunden-Volumen:
482.36K
Relative Volume:
0.50
Marktkapitalisierung:
$34.94M
Einnahmen:
$8.23M
Nettoeinkommen (Verlust:
$-32.49M
KGV:
-0.8396
EPS:
-0.53
Netto-Cashflow:
$-19.91M
1W Leistung:
+7.93%
1M Leistung:
-49.71%
6M Leistung:
-55.94%
1J Leistung:
-58.22%
1-Tages-Spanne:
$0.43
$0.4703
1-Wochen-Bereich:
$0.3691
$0.4703
52-Wochen-Spanne:
$0.292
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
Firmenname
Clearside Biomedical Inc
Sektor
Branche
Telefon
678-270-3631
Adresse
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Vergleichen Sie CLSD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.445 | 31.64M | 8.23M | -32.49M | -19.91M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-18 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-08-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2021-12-15 | Fortgesetzt | Wedbush | Outperform |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-09 | Herabstufung | Needham | Buy → Hold |
| 2018-11-05 | Herabstufung | Cowen | Outperform → Market Perform |
| 2018-11-05 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2018-11-05 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2017-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2017-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-10-24 | Bestätigt | Stifel | Buy |
Alle ansehen
Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten
Clearside Biomedical earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
Clearside Biomedical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Clearside Biomedical Inc. trending in predictive chart modelsFree Growth Focused Entry Plan Suggestions - Newser
Chart based exit strategy for Clearside Biomedical Inc.Smart Safety Strategy With Real Data Analysis - Newser
Applying chart zones and confluence areas to Clearside Biomedical Inc.Weekly Return Plan for Conservative Traders - Newser
How Clearside Biomedical Inc. stock performs during market volatilityFree Triple Digit Growth Focused Trade Plan - Newser
Clearside Biomedical 2025 Q2 Earnings Narrowed Losses Amid Strong Revenue Surge - AInvest
Clearside Biomedical's Liquidity Crisis and Strategic Overhaul: A High-Risk Bet or a Path to Renewal? - AInvest
Clearside Biomedical CLSD 2025Q2 Earnings Preview Upside Potential on Strategic Collaborations - AInvest
Clearside Biomedical Q2 Earnings: Revenue Beats Estimates, Shares Down 59.7% YTD - AInvest
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Clearside Biomedical Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Using data tools to time your Clearside Biomedical Inc. exitFree Low Volatility Stable Growth Picks - Newser
Clearside Biomedical Inc. stock prediction for this weekFree AI Driven Stock Trend Forecast - Newser
Custom watchlist performance reports with Clearside Biomedical Inc.Profit Target Planning with Exit Confidence - Newser
What makes Clearside Biomedical Inc. stock price move sharplyTrade Flow Monitor with Volume Tracker - Newser
Elliott Wave Theory Predicts Pullback in Clearside Biomedical Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Published on: 2025-08-04 17:07:21 - metal.it
What analysts say about Clearside Biomedical Inc. stockExceptional gains - Jammu Links News
Is Clearside Biomedical Inc. a growth stock or a value stockUnlock powerful market trend analysis - Jammu Links News
Is it the right time to buy Clearside Biomedical Inc. stockUnlock powerful stock screening for profits - Jammu Links News
Why is Clearside Biomedical Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk mitigation - Jammu Links News
Is Clearside Biomedical Inc. stock overvalued or undervaluedInvest smarter with daily market updates - Jammu Links News
What are the latest earnings results for Clearside Biomedical Inc.Rapid growth opportunities - Jammu Links News
Does Clearside Biomedical Inc. stock perform well during market downturnsUnstoppable trading performance - Jammu Links News
How does Clearside Biomedical Inc. generate profit in a changing economyGet professional advice for market timing - Jammu Links News
When is Clearside Biomedical Inc. stock expected to show significant growthUnlock daily market insights for better decisions - Jammu Links News
How volatile is Clearside Biomedical Inc. stock compared to the marketSuperior trading gains - Jammu Links News
Should I hold or sell Clearside Biomedical Inc. stock in 2025Free Popular Stock Recommendations - Jammu Links News
How does Clearside Biomedical Inc. compare to its industry peersBuild wealth faster with disciplined trading - Jammu Links News
What are Clearside Biomedical Inc. company’s key revenue driversGet timely alerts on market movers - Jammu Links News
How Resilient Is Clearside Biomedical Inc. Stock During Economic DownturnsStock Entry Point Planner with Volume Spike - Newser
Clearside Biomedical Inc. Added to High Probability Setup ListChart Driven High Reward Trading Setup Presented - beatles.ru
Strategies to average down on Clearside Biomedical Inc.Market Stability and Long-Term Growth Outlook - Newser
Competitive Positioning of Clearside Biomedical Inc.: Is It Leading or LaggingEquity Market Return Forecast Model Update - Newser
Chart overlay techniques for tracking Clearside Biomedical Inc.Sector-Wise Equity Performance Trend Forecast - Newser
Advanced analytics toolkit walkthrough for Clearside Biomedical Inc.Triple Digit Gain Opportunity Watchlist - Newser
Automated trading signals detected on Clearside Biomedical Inc.Free Smart Allocation Stock Pick Insights - Newser
Clearside Biomedical Inc. stock outlook for YEARSwing Entry Risk Mitigation with Chart Analysis - Newser
What is Clearside Biomedical Inc. company’s growth strategyMarket Forecast Tracker For Smart Trading - jammulinksnews.com
Why Clearside Biomedical Inc. stock is on top investor watchlistsLong-Term Allocation Strategy Summary Breakdown - Newser
What institutions are buying Clearside Biomedical Inc. stock nowRisk Shielded Trade Watch with Analysis - Newser
Published on: 2025-07-31 06:18:59 - metal.it
Using portfolio simulators with Clearside Biomedical Inc. includedLong-Term Signal Tracking and Profit Summary - Newser
Clearside Biomedical Inc. Breakout Confirmed by Volume MetricsAI Based High Gain Watchlist Scanner Shared - metal.it
Published on: 2025-07-30 14:02:11 - metal.it
Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):